The R&D team at Inga has developed expertise in pharmaceutical research with competencies developed in analytical method validation, scale-up batch manufacturing, bio-equivalence studies, validation studies and commercial batch manufacturing. Currently the team is involved in the development of a number of immediate release and sustained release formulations. Products are also being developed utilizing alternate routes of drug delivery (topical and transdermal products).

The above research has facilitated the creation of experienced teams to carry out solubility studies, partition co-efficient studies, pKa determination, polymorphism studies, stability studies, isolation and identification of impurities and degradation products, stress modelling for drug substances and formulations